ReGenesys announces Cell Therapy Manufacturing Award
ReGenesys, subsidiary of Athersys, Inc. announced it recently received the BioProcess International Award for the “Technical Application of the Decade” in Manufacturing for its development of an automated bioreactor system for the production of MultiStem®, Athersys’ proprietary, off-the-shelf stem cell therapy.
The work conducted by ReGenesys scientists, with the support of Terumo BCT, demonstrates that MultiStem cell therapy can be successfully manufactured in an automated bioreactor system. Unlike other cell therapies, the MultiStem product may be manufactured on a large scale, allowing potentially up to a million or more doses to be produced from a single donor. This is enabled by unique biological characteristics that allow for substantial expansion of the cell product in culture, while maintaining potency and product consistency.
“MultiStem has some key advantages relative to other cell therapy approaches, including superior expansion potential, scalability, and distinctive therapeutic properties. This award represents an important demonstration of the manufacturability of MultiStem cells in automated bioreactor systems,” said David Craeye, Sr. Scientist at ReGenesys. “I am excited by the progress made by my team and remain committed to building on our inherent expansion advantages to develop the best-in-class commercial manufacturing platform,” commented Jef Pinxteren, Head R&D.
Other news from the department research and development
These products might interest you

Flexcell Zelldehnungsbioreaktoren für zelluläre Biomechanik-Anwendungen by Dunn
Cell Stretching Bioreactors for Life Science Research
Used in over 1300 laboratories worldwide, and cited in over 9000 research publications

Biostat STR by Sartorius
Biostat STR Generation 3 Bioreactors
Engineered for Ultimate Upstream Performance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.